SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-23-212300
Filing Date
2023-08-14
Accepted
2023-08-14 16:06:09
Documents
45
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d504368d10q.htm   iXBRL 10-Q 795200
2 EX-31.1 d504368dex311.htm EX-31.1 11267
3 EX-31.2 d504368dex312.htm EX-31.2 11279
4 EX-32.1 d504368dex321.htm EX-32.1 4201
5 EX-32.2 d504368dex322.htm EX-32.2 4137
  Complete submission text file 0001193125-23-212300.txt   4169046

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA kvsa-20230630.xsd EX-101.SCH 32376
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kvsa-20230630_cal.xml EX-101.CAL 22197
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kvsa-20230630_def.xml EX-101.DEF 195137
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE kvsa-20230630_lab.xml EX-101.LAB 253028
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kvsa-20230630_pre.xml EX-101.PRE 235363
39 EXTRACTED XBRL INSTANCE DOCUMENT d504368d10q_htm.xml XML 658205
Mailing Address 2128 SAND HILL ROAD MENLO PARK CA 94025
Business Address 2128 SAND HILL ROAD MENLO PARK CA 94025 650-376-8500
Khosla Ventures Acquisition Co. (Filer) CIK: 0001841873 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40131 | Film No.: 231169859
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences